New 'One-Shot-Fits-Many' HPV vaccine enters human testing
NCT ID NCT05208710
Summary
This is a first-in-human safety study of PANHPVAX, a new experimental vaccine designed to prevent infections from many types of cancer-causing human papillomavirus (HPV). The trial will enroll 45 healthy adult volunteers to test increasing doses of the vaccine, with and without an immune-boosting additive, to see how safe it is and if it triggers a protective immune response. Unlike current HPV vaccines that target specific virus types, this new vaccine aims to provide broader protection against multiple HPV strains linked to cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Department of Clinical Pharmacology and Pharmacoepidemiology
RECRUITINGHeidelberg, 69120, Germany
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.